UTS2B

gene
On this page

Also known as URPU2B

Summary

UTS2B (urotensin 2B, HGNC:30894) is a protein-coding gene on chromosome 3q28, encoding Urotensin-2B (Q765I0). Potent vasoconstrictor.

Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region.

Source: NCBI Gene 257313 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 21 total
  • MANE Select transcript: NM_198152

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30894
Approved symbolUTS2B
Nameurotensin 2B
Location3q28
Locus typegene with protein product
StatusApproved
AliasesURP, U2B
Ensembl geneENSG00000188958
Ensembl biotypeprotein_coding
OMIM618134
Entrez257313

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000340524, ENST00000425357, ENST00000427544, ENST00000432514, ENST00000440476, ENST00000446788, ENST00000463450, ENST00000464814, ENST00000490825, ENST00000899455, ENST00000915518

RefSeq mRNA: 1 — MANE Select: NM_198152 NM_198152

CCDS: CCDS3300

Canonical transcript exons

ENST00000340524 — 9 exons

ExonStartEnd
ENSE00001369529191267168191268441
ENSE00001383373191276807191276844
ENSE00001512014191304492191304548
ENSE00001512015191316036191316439
ENSE00001512016191328631191328709
ENSE00001512017191330414191330526
ENSE00003531376191278072191278170
ENSE00003664443191282087191282313
ENSE00003687596191275252191275345

Expression profiles

Bgee: expression breadth ubiquitous, 146 present calls, max score 82.43.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3131 / max 230.7094, expressed in 24 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
461060.172317
461070.096918
461050.02164
461080.00972
461010.00411
461040.00392
461020.00281
461030.00181

Top tissues by expression

238 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.43gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.83gold quality
secondary oocyteCL:000065569.78gold quality
left testisUBERON:000453368.59gold quality
right testisUBERON:000453467.64gold quality
testisUBERON:000047367.44gold quality
stromal cell of endometriumCL:000225565.96gold quality
buccal mucosa cellCL:000233660.78gold quality
smooth muscle tissueUBERON:000113560.77gold quality
right uterine tubeUBERON:000130259.73gold quality
right lobe of liverUBERON:000111459.70gold quality
vermiform appendixUBERON:000115458.07gold quality
colonic epitheliumUBERON:000039757.66silver quality
liverUBERON:000210757.40gold quality
gall bladderUBERON:000211057.28gold quality
calcaneal tendonUBERON:000370156.80gold quality
bone marrow cellCL:000209256.31gold quality
right coronary arteryUBERON:000162556.03gold quality
rectumUBERON:000105255.88gold quality
small intestine Peyer’s patchUBERON:000345455.25gold quality
left ovaryUBERON:000211954.97gold quality
cortical plateUBERON:000534354.77gold quality
lymph nodeUBERON:000002954.61gold quality
caecumUBERON:000115354.13gold quality
small intestineUBERON:000210853.91gold quality
amygdalaUBERON:000187653.79gold quality
subcutaneous adipose tissueUBERON:000219053.49gold quality
omental fat padUBERON:001041453.46gold quality
upper leg skinUBERON:000426253.45silver quality
peritoneumUBERON:000235853.43gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-CURD-112yes8000.07
E-ANND-3no4.34

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

83 targeting UTS2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-126-5P100.0072.713180
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-8485100.0077.574731
HSA-MIR-480399.9871.993117
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-7152-3P99.9767.47849
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-101-3P99.9475.032230
HSA-MIR-144-3P99.9473.982698
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-338-5P99.9272.342951
HSA-MIR-652-5P99.9167.49505
HSA-MIR-130599.9171.433443
HSA-MIR-806299.8868.43995
HSA-MIR-469899.8471.414303
HSA-MIR-430799.8270.453374
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-128399.6972.423009
HSA-MIR-519A-3P99.6771.671868
HSA-MIR-519B-3P99.6771.671868
HSA-MIR-519C-3P99.6771.671870
HSA-MIR-58799.6470.862611
HSA-MIR-56799.6368.571219

Literature-anchored findings (GeneRIF, showing 7)

  • URP could possibly be the endogenous and functional ligand for the human UII receptor (PMID:14550283)
  • These findings suggest that U-II plays key roles in accelerating the development of atherosclerosis, thereby leading to coronary artery disease. (PMID:16940699)
  • Urotensin II gene may contribute to the genetic susceptibility to gestational diabetes mellitus in Chinese population (PMID:17327028)
  • Elevated serum urotensin II is associated with chronic liver disease and portal hypertension (PMID:17919235)
  • vascular remodelling processes in conjunction with enhanced vasoconstriction are involved in the pathogenesis of pulmonary hypertension; UII may play a novel role in the pathogenesis of this disorder (PMID:18000598)
  • U2B’’ has a relaxed specificity for its RNA targets. (PMID:21684671)
  • family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms (PMID:24391740)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusUts2bENSMUSG00000056423
rattus_norvegicusUts2bENSRNOG00000038512

Protein

Protein identifiers

Urotensin-2BQ765I0 (reviewed: Q765I0)

Alternative names: Urotensin II-related peptide, Urotensin IIB, Urotensin-2 domain-containing protein

All UniProt accessions (4): C9JU87, F2Z3I1, F8WCV4, Q765I0

UniProt curated annotations — full annotation on UniProt →

Function. Potent vasoconstrictor.

Subcellular location. Secreted.

Similarity. Belongs to the urotensin-2 family.

RefSeq proteins (1): NP_937795* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001483Urotensin_IIConserved_site
IPR043255U-IIBFamily

UniProt features (5 total): signal peptide 1, propeptide 1, peptide 1, disulfide bond 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q765I0-F166.820.06

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (1): 113–118

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-375276Peptide ligand-binding receptors
R-HSA-416476G alpha (q) signalling events

MSigDB gene sets: 60 (showing top): GOBP_REGULATION_OF_BLOOD_PRESSURE, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS, GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM, GOMF_HORMONE_ACTIVITY, REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS, REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOBP_REGULATION_OF_TUBE_SIZE, GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN, E2F2_TARGET_GENES, LHX9_TARGET_GENES

GO Biological Process (3): regulation of blood pressure (GO:0008217), blood vessel diameter maintenance (GO:0097746), signal transduction (GO:0007165)

GO Molecular Function (2): G protein-coupled receptor binding (GO:0001664), hormone activity (GO:0005179)

GO Cellular Component (1): extracellular region (GO:0005576)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Class A/1 (Rhodopsin-like receptors)1
GPCR downstream signalling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
blood circulation2
regulation of biological quality1
vascular process in circulatory system1
regulation of tube diameter1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
signaling receptor binding1
receptor ligand activity1
cellular anatomical structure1

Protein interactions and networks

STRING

512 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
UTS2BUTS2RQ9UKP6868
UTS2BUTS2O95399833
UTS2BSSTR2P30874512
UTS2BGNG4P50150472
UTS2BOSTNP61366461
UTS2BARHGAP36Q6ZRI8459
UTS2BFREM3P0C091456
UTS2BHTR1BP28222455
UTS2BVWC2Q2TAL6447
UTS2BACTN2P35609446
UTS2BRAB11FIP4Q86YS3442
UTS2BTMC3Q7Z5M5436
UTS2BCCL19Q99731434
UTS2BCORTO00230433
UTS2BZNF784Q8NCA9417

IntAct

2 interactions, top by confidence:

ABTypeScore
UTS2BRPN1psi-mi:“MI:0915”(physical association)0.400

BioGRID (2): UTS2R (Reconstituted Complex), UTS2B (Proximity Label-MS)

ESM2 similar proteins: A8WU84, C0HKT1, C0HKT3, C0HKU2, D2IT41, D2Z1D6, E2A3M7, E2A6Z3, E2AJ76, E2AX75, E2AZE8, E2E4L2, O96690, P05110, P09929, P0DQY8, P18145, P28672, P28673, P28674, P33715, P61849, P61855, P80111, P85527, P85798, P86442, Q11099, Q18184, Q18234, Q18502, Q27441, Q29B55, Q75UG5, Q765I0, Q76CL2, Q7Q7R8, Q868F8, Q8T112, Q8WRC7

Diamond homologs: Q765I0, Q765I1, Q765I2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

21 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance11
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1593 predictions. Top by Δscore:

VariantEffectΔscore
3:191329719:GGAAG:Gdonor_gain1.0000
3:191329720:G:GTdonor_gain1.0000
3:191329721:A:Tdonor_gain1.0000
3:191329722:AGGT:Adonor_loss1.0000
3:191329723:GGTAA:Gdonor_loss1.0000
3:191329724:G:Cdonor_loss1.0000
3:191329725:T:Gdonor_loss1.0000
3:191275355:T:TCacceptor_gain0.9900
3:191277428:T:TAdonor_gain0.9900
3:191329720:GAAG:Gdonor_gain0.9900
3:191329724:G:GGdonor_gain0.9900
3:191276865:A:Cacceptor_gain0.9800
3:191277425:A:ACdonor_gain0.9800
3:191277426:C:CCdonor_gain0.9800
3:191275346:C:CCacceptor_gain0.9700
3:191329376:A:ACdonor_gain0.9700
3:191329377:C:CCdonor_gain0.9700
3:191330410:TGACC:Tdonor_loss0.9700
3:191330411:GACCT:Gdonor_loss0.9700
3:191330412:ACCTG:Adonor_loss0.9700
3:191330413:CCT:Cdonor_loss0.9700
3:191330413:CCTGG:Cdonor_gain0.9700
3:191275349:A:Cacceptor_gain0.9600
3:191275342:CCAG:Cacceptor_gain0.9500
3:191275343:CAG:Cacceptor_gain0.9500
3:191275343:CAGC:Cacceptor_gain0.9500
3:191275355:T:Cacceptor_gain0.9500
3:191329722:AG:Adonor_gain0.9500
3:191329723:GG:Gdonor_gain0.9500
3:191330449:C:Adonor_gain0.9500

AlphaMissense

768 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:191268431:C:AW115C0.990
3:191268431:C:GW115C0.990
3:191268434:A:CF114L0.983
3:191268434:A:TF114L0.983
3:191268436:A:GF114L0.983
3:191268429:T:AK116I0.978
3:191268428:T:AK116N0.968
3:191268428:T:GK116N0.968
3:191268433:A:GW115R0.966
3:191268433:A:TW115R0.966
3:191268435:A:CF114C0.964
3:191268427:A:GY117H0.963
3:191268429:T:GK116T0.963
3:191268426:T:CY117C0.961
3:191268430:T:CK116E0.950
3:191268420:A:TV119D0.949
3:191268437:G:CC113W0.948
3:191268439:A:GC113R0.946
3:191268438:C:TC113Y0.943
3:191268435:A:GF114S0.938
3:191268423:C:TC118Y0.937
3:191268424:A:GC118R0.937
3:191268432:C:GW115S0.933
3:191268422:A:CC118W0.932
3:191268438:C:GC113S0.930
3:191268439:A:TC113S0.930
3:191268430:T:GK116Q0.915
3:191268423:C:GC118S0.912
3:191268424:A:TC118S0.912
3:191268426:T:GY117S0.911

dbSNP variants (sampled 300 via entrez): RS1000041398 (3:191295220 C>T), RS1000068247 (3:191271913 A>C), RS1000071753 (3:191312853 A>C), RS1000091811 (3:191295503 T>C), RS1000131421 (3:191300254 T>C), RS1000143281 (3:191339032 C>G,T), RS1000255227 (3:191328910 A>C,G), RS1000262574 (3:191289364 G>A,T), RS1000265189 (3:191276334 C>A,G,T), RS1000282294 (3:191315834 T>C), RS1000300668 (3:191294191 G>T), RS1000305029 (3:191289147 C>T), RS1000356137 (3:191327617 A>C), RS1000362937 (3:191294633 A>T), RS1000363923 (3:191283634 G>T)

Disease associations

OMIM: gene MIM:618134 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST000892_2Total ventricular volume (Alzheimer’s disease interaction)9.000000e-06
GCST001951_1Alzheimer’s disease biomarkers5.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004760t-tau measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1decreases methylation, increases expression2
bisphenol Aaffects cotreatment, decreases methylation1
2,2’,4,4’,5-brominated diphenyl etherincreases expression1
belinostatdecreases expression1
abrineincreases expression1
NSC 689534affects binding, decreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Copperaffects binding, decreases expression1
Phenobarbitaldecreases expression1
Smokedecreases expression1
Valproic Aciddecreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.